Skip to main content
Premium Trial:

Request an Annual Quote

Children's Mercy Kansas City Kiddose PGx Test

Pediatric health organization Children's Mercy Kansas City has launched the Kiddose PGx test, making it the first pediatric hospital in Missouri to offer in-house pharmacogenetic testing, the organization said. Pharmacogenetic testing has been part of clinical decision making at Children's Mercy since 2014, it added, but tests previously were sent to external labs. By analyzing how a patient's genes affect responses to medications, Kiddose PGx aims to enhance medication efficacy, minimize potential side effects, and improve treatment outcomes in therapeutic areas such as cancer, organ transplantation, chronic illness, and developmental or behavioral disorders.